Project Grant R21AI193098
Award Date
6/18/25
Completion Date
5/31/27
Dollars Obligated
$430K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New Mexico, USA
Similar Awards
This $369,431 federal project grant award from the National Institutes of Health's (NIH) Allergy and Infectious Diseases Research program (CFDA 93.855) supports research at the University of Wisconsin - Eau Claire to study the molecular and behavioral characteristics of schistosome miracidia, the aquatic larval stage that infects snail hosts and causes schistosomiasis in humans. The project aims to quantitatively describe miracidia behaviors, extract behavioral fingerprints, and validate the key...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $700,288 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of South Florida (USF) to conduct phenotype-based screens and functional genomics research to identify genetic factors associated with gametocyte development in Plasmodium falciparum, the major global cause of malaria. The project, running from November 2024 to October 2029, will use a random piggyBac mutagenesis approach to...
This $196,163 federal Project Grant award from the National Science Foundation (NSF) under the Mathematical and Physical Sciences program (CFDA 47.049) is funding a collaborative research project on developing advanced mathematical models to improve understanding and management of schistosomiasis transmission dynamics. The project is a collaboration between the University of Florida, University of Georgia, and University of Massachusetts, and aims to create innovative hybrid...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $810,158 to The University of Texas Health Science Center at San Antonio (UTHSCSA) to develop a novel antischistosomal compound to treat human schistosomiasis, a disease that affects over 200 million people globally. The research aims to optimize an oxamniquine (OXA) derivative that has shown broad activity against the...
This Project Grant award of $133,203 was provided by the National Science Foundation (NSF) through its Mathematical and Physical Sciences (CFDA 47.049) program. The award supports a collaborative research project among the University of Florida, University of Georgia, and University of Massachusetts Amherst to develop advanced mathematical models to improve understanding and management of schistosomiasis transmission dynamics, with a focus on the transition from high to low transmission phases...
This Project Grant award of $791,864, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify the molecular factors that control chromatin organization and gene regulation in the malaria parasite Plasmodium falciparum. The primary goal is to elucidate the importance of long non-coding RNAs (lncRNAs) in parasite development, virulence, and sexual differentiation, and...
This federal Project Grant award in the amount of $800,624, provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research), aims to develop novel inhibitors of the enzyme thioredoxin glutathione reductase (TGR) for the treatment of schistosomiasis, a parasitic disease affecting over 200 million people worldwide. The key objectives are to optimize the potency, selectivity, and drug-like properties of TGR inhibitors through...
This federal Project Grant award of $769,201 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to discover optimal combinations of Bacillus thuringiensis (Bt) crystal proteins and small molecule anthelmintic drugs to suppress drug resistance and improve efficacy in treating parasitic gastrointestinal nematode (GIN) infections. The research aims to 1) identify strong synergistic...
This $147,656 federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the role of transmembrane proteins in the cell division process of the malaria parasite Plasmodium falciparum. The award, effective January 22, 2025 through October 31, 2027, will enable the integration of biochemical and super-resolution microscopy approaches to decipher...
This $1,108,345 federal Project Grant award, funded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to characterize the evolutionary transition of host-microbe interactions from commensal symbionts to blood parasites in apicomplexan organisms, which include the parasites that cause malaria. The project, led by the University of Rhode Island, will use advanced microscopy and genomics to compare the cellular invasion machinery between...